Billy Evans, the partner of Theranos founder Elizabeth Holmes, is raising funds for a new artificial intelligence startup named Haemanthus, which focuses on medical testing applications. Despite Holmes serving an 11-year sentence for fraud tied to Theranos, she has been advising Evans from prison. Their involvement raises ethical questions about the biotech industry. The startup team includes former associates from Evans's previous job. Holmes, who has maintained her innocence throughout her trial, continues to influence the sector even from incarceration, highlighting her persistence despite past failures.
The partner of Theranos founder Elizabeth Holmes has raised millions for an AI startup, Haemanthus, aiming to introduce a medical testing product.
Holmes, now serving an 11-year prison sentence for fraud, advises her partner Billy Evans on the startup, reflecting her ongoing influence.
Despite her conviction, Holmes supports Evans's new venture, raising questions about ethics in biotech given her previous misleading actions with Theranos.
Holmes's trial revealed her insistence that she committed no crimes, maintaining her innocence despite evidence of deceit toward investors.
Collection
[
|
...
]